FBA reveals guanylate kinase as a potential target for antiviral therapies against SARS-CoV-2

MOTIVATION: The novel coronavirus (SARS-CoV-2) currently spreads worldwide, causing the disease COVID-19. The number of infections increases daily, without any approved antiviral therapy. The recently released viral nucleotide sequence enables the identification of therapeutic targets, e.g. by analy...

Descripción completa

Detalles Bibliográficos
Autores principales: Renz, Alina, Widerspick, Lina, Dräger, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Systems
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773487/
https://www.ncbi.nlm.nih.gov/pubmed/33381848
http://dx.doi.org/10.1093/bioinformatics/btaa813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7773487/
https://www.ncbi.nlm.nih.gov/pubmed/33381848
http://dx.doi.org/10.1093/bioinformatics/btaa813

Ejemplares similares